Journal article
EE68 Assessment of the Cost Utility of Palivizumab for Preventing Severe Respiratory Syncytial Virus (RSV) Infection in Preterm Infants Born 29-35 Weeks' Gestational Age in the Philippines
Authors
Del Rosario-Famadico S; Carbonell-Estrany X; Paes B; Tarride J-E; Rodgers-Gray B; Keary I; Fullarton J
Journal
Value in Health, Vol. 28, No. 12,
Publisher
Elsevier
Publication Date
December 1, 2025
DOI
10.1016/j.jval.2025.09.452
ISSN
1098-3015